A New Method for Ileostomy Output Collection Using an Intestinal Tampon
1 other identifier
interventional
10
1 country
1
Brief Summary
The goal of this interventional study is to learn if a specialized absorbent intestinal tampon can effectively collect ileostomy output. The main questions it aims to answer are:
- Can participants successfully self-insert the intestinal tampon?
- What is the level of discomfort or pain associated with the insertion and use of the tampon? Researchers will compare different tampon designs and coatings to find the most suitable one for insertion and retention. Participants will:
- Be observed and interviewed during the insertion of the tampon by a medical consultant.
- Self-insert the tampon under supervision and later independently.
- Provide feedback on their experience, including any discomfort or pain using a numerical rating scale (NRS).
- Provide stool samples before and after using the tampon for microbiome analysis. This study aims to determine the feasibility and user acceptance of the intestinal tampon as an alternative to traditional stoma bags, potentially reducing complications and improving the quality of life for people with an ileostomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2024
CompletedFirst Submitted
Initial submission to the registry
January 20, 2025
CompletedFirst Posted
Study publicly available on registry
March 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedDecember 5, 2025
December 1, 2025
8 months
January 20, 2025
December 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of Self-Insertion of the Intestinal Tampon
This measure will assess the feasibility of self-inserting the specialized absorbent intestinal tampon. Feasibility will be determined by the percentage of successful insertions, as well as participant feedback and medical consultant observations, which will be reported separately.
Day 1 and Day 2 of the study
Secondary Outcomes (2)
Level of Discomfort or Pain During Insertion and Use
Day 2 of the study
Changes in Microbiota Composition
Before and after tampon use on Day 2
Study Arms (1)
Specialized Absorbent Intestinal Tampon Group
EXPERIMENTALParticipants in this arm will receive the specialized absorbent intestinal tampon designed to collect ileostomy output. The study will evaluate the feasibility, safety, and user acceptance of the tampon.
Interventions
The specialized absorbent intestinal tampon is designed to be self-inserted by participants with ileostomies. It aims to collect ileostomy output and improve the quality of life by reducing complications associated with traditional stoma bags. The study will test different tampon designs and coatings to find the most suitable one for insertion and retention. Participants will be observed and interviewed during the insertion process, and their feedback on discomfort or pain will be collected using a numerical rating scale (NRS). Stool samples will be collected before and after tampon use for microbiota analysis.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Ileostomy \> 6 months old
- Stoma opening ≥ 10 mm in diameter
- Written informed consent
You may not qualify if:
- Difficulty understanding study information, including language barriers
- Somatic illness, including active inflammatory bowel disease
- Hernia around the stoma
- Daily output \> 2 liters
- Active inflammation in the ileum (diagnosed within 2 months before the study day)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ampa Medicallead
Study Sites (1)
Ampa Medical
Copenhagen, 1620, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor (MD, PhD)
Study Record Dates
First Submitted
January 20, 2025
First Posted
March 26, 2025
Study Start
December 10, 2024
Primary Completion
July 31, 2025
Study Completion
August 31, 2025
Last Updated
December 5, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share